STOCK TITAN
  1. Home
  2. HZNP

Horizon Therapeutics Pub L (HZNP) Stock Price, News & Analysis

HZNP NASDAQ

Company Description

Horizon Therapeutics Pub L (NASDAQ: HZNP) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for HZNP, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All
0.00%

Rule 17(e) Announcement - Horizon Therapeutics plc

+0.04%

Rule 17(d) Announcement – Horizon Therapeutics plc

+0.26%

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

+0.21%

Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023

0.00%

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

0.00%

New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes

Horizon Therapeutics Pub L has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial. View all HZNP news →

SEC Filings

View All

No SEC filings available for HZNP.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

HZNP Company Profile & Sector Positioning

Horizon Therapeutics Pub L (HZNP) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.